Specialty
Aesthetics Cataract & Refractive Dermatology General Ophthalmology Glaucoma Interventional Radiology Neurology Optometry Retina Women's Health View All Courses
Course Type
Supplement Multimedia Webinar In-Person Multi-Part Collection
Search
Log In

Beyond Face Value – Part 2

By: Sachin M. Shridharani, MD; Navin Singh, MD

This course has expired. You can still review the content but course credit is no longer available.

Webinar Credits: 1

When it comes to minimally-invasive facial rejuvenation, what's possible with today's tools? What's expected? What's appropriate? Sachin M. Shridharani, MD and Navin Singh, MD outline principles of facial aesthetics, discuss important anatomical considerations, review data about patient expectations, and outline effective approaches to full-face rejuvenation. This webinar is the second part of a two part series.

Expiration Date: Sunday, September 30, 2018
Release Date: September 2017

Learning Objectives

Upon completion of this activity, the participant should be able to:

  • Describe the properties of different injectable fillers and explain how these properties provide different lifting/filling effects.
  • Devise strategies for facial rejuvenation that employ the unique characteristics of different fillers to achieve complementary effects.
  • Identify opportunities for combination strategies for rejuvenation that optimize aesthetic outcomes, patient convenience, cost, and satisfaction.
  • Describe the potential effects of facial rejuvenation on the patient psyche and discuss possible impact on quality of life.
  • Utilize strategies to elicit patient desires and deliver combination approaches to facial rejuvenation that meet patient objectives.

Accreditation and Designation Statement

Accreditation Statement
Evolve Medical Education LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA Credit Designation Statement
Evolve Medical Education LLC designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty and Disclosures

The following faculty members have the following financial relationships with commercial interests:
Sachin Shridharani, MD and or spouse has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board: Allergan plc; Galderma Laboratories L.P.;  Merz; and Mira Mar, Inc. Grant/Research Support: Allergan plc.; Galderma Laboratories L.P.; Merz and Mira Mar, Inc. Speaker’s Bureau: Allergan plc; Galderma Laboratories L.P.;  and Mira Mar, Inc.

Navin Singh, MD and or spouse has had no financial agreements or affiliations during the past year.

Editorial Support Disclosure
Cheryl Cavanaugh, MS, Evolve Medical Education LLC and Anthony Rossi, Peer Reviewer, have no financial agreements with commercial interests.

Disclaimer

OFF-LABEL STATEMENT
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
DISCLAIMER
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve,  or Allergan.

REFERENCES

1 Hancox JG, Venkat AP, Coldiron B, Feldman SR, Williford PM. The safety of office-based surgery: review of recent literature from several disciplines. Arch Dermatol. 2004 Nov;140(11):1379-82. 2 2.Fagien S, Cassuto D. Reconstituted injectable hyaluronic acid: expanded applications in facial aesthetics and additional thoughts on the mechanism of action in cosmetic medicine. Plast Reconstr Surg. 2012 Jul;130(1):208-17.

3 Coleman SR. Avoidance of arterial occlusion from injection of soft tissue fillers. Aesthet Surg J. 2002 Nov;22(6):555-7.

4 Zeichner JA, Cohen JL. Use of blunt tipped cannulas for soft tissue fillers. J Drugs Dermatol. 2012 Jan;11(1):70-2.

5 Fulton J, Caperton C, Weinkle S, Dewandre L. Filler injections with the blunt-tip microcannula. J Drugs Dermatol. 2012 Sep;11(9):1098-103.

6 Hexsel D, Soirefmann M, Porto MD, Siega C, Schilling-Souza J, Brum C. Double-blind, randomized, controlled clinical trial to compare safety and efficacy of a metallic cannula with that of a standard needle for soft tissue augmentation of the nasolabial folds. Dermatol Surg. 2012 Feb;38(2):207-14.

7 Rzany B, Becker-Wegerich P, Bachmann F, Erdmann R, Wollina U. Hyaluronidase in the correction of hyaluronic acid-based fillers: a review and a recommendation for use. J Cosmet Dermatol. 2009 Dec;8(4):317-23.

8 Goldberg RA, Fiaschetti D. Filling the periorbital hollows with hyaluronic acid gel: initial experience with 244 injections. Ophthal Plast Reconstr Surg. 2006 Sep-Oct;22(5):335-41

9 Hirsch RJ, Brody HJ, Carruthers JD. Hyaluronidase in the office: a necessity for every dermasurgeon that injects hyaluronic acid. J Cosmet Laser Ther. 2007 Sep;9(3):182-5.

10 Smith SR, Jones D, Thomas JA, Murphy DK, Beddingfield FC 3rd. Duration of wrinkle correction following repeat treatment with Juvéderm hyaluronic acid fillers. Arch Dermatol Res. 2010 Dec;302(10):757-62.

11 Zielke H, Wölber L, Wiest L, Rzany B. Risk profiles of different injectable fillers: results from the Injectable Filler Safety Study (IFS Study). Dermatol Surg. 2008 Mar;34(3):326-35

12 Luebberding S, Alexiades-Armenakas M. Safety of dermal fillers. J Drugs Dermatol. 2012 Sep;11(9):1053-8.

13 Cohen JL, Dayan SH, Brandt FS, Nelson DB, Axford-Gatley RA, Theisen MJ, Narins RS. Systematic review of clinical trials of small- and large-gel-particle hyaluronic acid injectable fillers for aesthetic soft tissue augmentation. Dermatol Surg. 2013 Feb;39(2):205-31.

14 Glogau RG, Kane MA. Effect of injection techniques on the rate of local adverse events in patients implanted with nonanimal hyaluronic acid gel dermal fillers. Dermatol Surg. 2008 Jun;34 Suppl 1:S105-9.

15 Arlette JP, Trotter MJ. Anatomic location of hyaluronic acid filler material injected into nasolabial fold: a histologic study. Dermatol Surg. 2008 Jun;34 Suppl 1:S56-62

16 Dermatol Surg. 2012 Jul;38(7 Pt 2):1162-9. doi: 10.1111/j.1524-4725.2012.02471.x. Superficial dermal injection of hyaluronic acid soft tissue fillers: comparative ultrasound study. Micheels P, Besse S, Flynn TC, Sarazin D, Elbaz Y.

17 Narurkar V, et al. Cosmetic Injectables: Emerging Uses, Techniques, And Data. Practical Dermatology. 2013; 10(6 Supplement).

18 Wollina U. Facial rejuvenation starts in the midface: three-dimensional

volumetric facial rejuvenation has beneficial effects on nontreated neighboring

esthetic units. J Cosmet Dermatol. 2015 Aug 25

19 Cuerda-Galindo E, Palomar-Gallego MA, Linares-Garcíavaldecasas R. Are combined

same-day treatments the future for photorejuvenation? Review of the literature on

combined treatments with lasers, intense pulsed light, radiofrequency, botulinum

toxin, and fillers for rejuvenation. J Cosmet Laser Ther. 2015 Feb;17(1):49-54.

20 Seery T. Modern Aesthetics May/June 2015. Vol 3., No. 4

21 Dayan SH. Mind, Mood, and Aesthetics Aesthetic Surgery Journal 2015; doi: 10.1093/asj/sjv03

Video Resources

Part one

Part two

BackNext